“
JACDA's translational expertise has been instrumental in aligning our diagnostic prototypes with real-world clinical requirements.
Sample Testimonial: Collaborator
“
The mentorship provided through JACDA's scientific capacity-building program has significantly advanced my ability to design clinical studies.
Sample Testimonial: Trainee
Our Impact
JACDA, LLC provides Clinical & Translational Research Solutions that help healthcare, biotechnology, diagnostic, and research organizations turn complex science into clinically relevant strategies. We focus on smoke-related lung injury, oncology diagnostics using nanotechnologies, translational science, and health equity.
Case Studies
Smoke-Related Lung Injury
Developing novel clinical assessment frameworks for early identification of lung injury biomarkers, facilitating timely intervention and longitudinal monitoring in populations at risk.
Oncology Diagnostics Using Nanotechnologies
Pioneering microchip-based oncology screening tools that utilize nanotechnologies for rapid, ultra-sensitive detection of biomarkers, significantly shortening the diagnostic cycle.
Translational Science & Clinical Study Design
Bridging discovery science with regulatory compliance through rigorous clinical study designs that validate next-generation sensing platforms for clinical implementation.
Health Equity in Research
Integrating health equity metrics into diagnostic protocols, ensuring that biomedical innovations address disparities in access and diagnostic accuracy across diverse geographic regions.
Ready to Transform Discovery into Impact?
Partner with JACDA to accelerate your Clinical & Translational Research Solutions. Let's start a conversation today.
Start a Conversation
Discuss your Clinical & Translational Research needs with our diagnostic innovation experts.
Case Studies & Impact
JACDA, LLC provides Clinical & Translational Research Solutions that turn complex diagnostics into real-world impact. Here are examples of how we support smoke-related lung injury, oncology diagnostics using nanotechnologies, translational science, and health equity.
Smoke-Related Lung Injury
Designed and led studies on smoke-related lung injury, focusing on airway repair pathways and inflammatory signaling to inform future therapeutic strategies.
Oncology Diagnostics Using Nanotechnologies
Developed and evaluated nanotechnology-enabled platforms to support oncology diagnostics and imaging, advancing proof-of-concept tools for earlier and more precise tumor assessment.
Translational Science & Clinical Study Design
Provided clinical and translational research strategy, including study design, endpoint selection, and protocol development to move promising concepts toward IRB-ready, fundable studies.
Health Equity in Research
Supported projects that integrate equity-focused analytics into smoke-related lung injury and oncology research, helping shape more equitable diagnostic strategies for underserved communities.
Sample Testimonials
"The clinical research solutions provided by JACDA were instrumental in our diagnostic validation process. Their translational science expertise bridged a critical gap for our team."
— Principal Investigator, Research Institute
"Mentorship through JACDA's capacity-building programs empowered our junior scientists with the methodology needed for complex clinical study design and biomarker analytics."
— Trainee & Research Associate
Years in Clinical, Academic & Translational Research
20+
Peer-Reviewed Publications
50+
Grants Supported (as PI, co-PI, mentor, or reviewer)
30+
Trainees Mentored Across Career Stages
60+
Voice of Impact
Hear from our collaborators and the trainees who have worked with JACDA on diagnostic developments and clinical innovations.
“Collaborating with JACDA provided the clinical framework we needed to move our nanotechnology diagnostic platform into validation. Their expertise in smoke-related lung injury was pivotal for our current study design.”
Clinical Research Collaborator
“The mentorship and scientific capacity-building at JACDA helped me bridge the gap between biomedical engineering and health equity metrics in oncology diagnostics.”
Diagnostic Innovation Trainee